Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation

BACKGROUND: Safety regarding switching from vitamin K antagonist (VKA) to dabigatran therapy in post-ablation patients has never been investigated and safety data for this is urgently needed. The objective of this study was to examine if switch from VKA to dabigatran increased the risk of stroke, bl...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Pallisgaard, Jannik Langtved, Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Lee, Christina Ji-Young, Sindet-Pedersen, Caroline, Staerk, Laila, Olesen, Jonas Bjerring, Lindhardt, Tommi Bo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999147/
https://ncbi.nlm.nih.gov/pubmed/27560967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0161768
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg